Operating

Change In Fair Value Of Preferred Stock Tranche Right Liability

Kailera Therapeutics Change In Fair Value Of Preferred Stock Tranche Right Liability decreased by 100.0% to $0.00 in Q1 2026 compared to the prior quarter.

Analysis

StatementCash Flow Statement
SectionOperating
First reportedQ1 2025
Last reportedQ1 2026May 26, 2026
Metric ID: operating_change_in_fair_value_of_preferred_stock_tranch_9173f5

Historical Data

2 periods
 Q1 '25Q1 '26
Value$800.00K$0.00
QoQ Change—-100.0%
YoY Change—-100.0%
Range$0.00 – $800.00K
Avg YoY Growth-100.0%
Median YoY Growth-100.0%

Frequently Asked Questions

What is Kailera Therapeutics 's change in fair value of preferred stock tranche right liability?
Kailera Therapeutics (KLRA) reported change in fair value of preferred stock tranche right liability of $0.00 in Q1 2026.